Robert Langreth - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Robert Langreth's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Robert Langreth

Robert Langreth

Verified

Science and Health Reporter-at-Large, Bloomberg News

New York

Final Covers

Biotechnology , Pharmaceuticals , Medicine , Healthcare

Doesn’t Cover

I don't typically write about fashion or politics

Journalist Type

Medium Formats

Content

Total articles 3748

  • Deaths Linked to Alzheimer's Drug Spur Concerns Over Who Gets It (2)

    By Robert Langreth Verified, Gerry Smith Verified| Bloomberg Tax Verified Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headachesif she tried a new drug from Eisai Co. that promised to slow the progression of her disease. It didn’t sound like a dealbreaker, so she decided to try it. Two weeks after her third dose, Aaron was dead.

    By Robert Langreth Verified, Gerry Smith Verified · Bloomberg Tax

    Mar. 31, 2025

  • Deaths Linked to Alzheimer's Drug Spur Concerns Over Who Gets It (2)

    By Robert Langreth Verified, Gerry Smith Verified| Bloomberg Law Verified Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headachesif she tried a new drug from Eisai Co. that promised to slow the progression of her disease. It didn’t sound like a dealbreaker, so she decided to try it. Two weeks after her third dose, Aaron was dead.

    By Robert Langreth Verified, Gerry Smith Verified · Bloomberg Law

    Mar. 31, 2025

  • Deaths Linked to Alzheimer's Drug Spur Concerns Over Who Gets It (2)

    By Robert Langreth Verified, Gerry Smith Verified| Bloomberg Tax Verified Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headachesif she tried a new drug from Eisai Co. that promised to slow the progression of her disease. It didn’t sound like a dealbreaker, so she decided to try it. Two weeks after her third dose, Aaron was dead.

    By Robert Langreth Verified, Gerry Smith Verified · Bloomberg Tax

    Mar. 31, 2025

As seen in

Company Info

Bloomberg News

Bloomberg L.P. is a global financial data, software, and media company founded in 1981 by Michael Bloomberg and his partners. Originally named Innovative Market Systems, it rebranded to Bloomberg L.P. in 1986. The company is renowned for the Bloomberg Terminal, a proprietary platform that provides real-time financial data, analytics, and trading tools to over 350,000 subscribers worldwide. Bloomberg operates in three main areas: financial technology, news/media, and data analytics. Its flagship product, the Bloomberg Terminal, offers market data, news, and communication tools for financial professionals. Bloomberg News, with over 120 bureaus globally, covers financial markets, politics, and technology across various platforms, including digital, television, and print. The company also provides specialized data and analytics services, including legal and regulatory information, through its acquisitions. Bloomberg L.P. is privately held, with an estimated revenue of $12.5 billion in 2023, primarily from terminal subscriptions.

'+1 212-318-2000

Founded: 1981